BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23656271)

  • 1. Long-term outcomes in patients with duodenal adenocarcinoma.
    Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
    ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
    Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
    Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
    Bucher P; Gervaz P; Morel P
    Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
    Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
    Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
    Rose DM; Hochwald SN; Klimstra DS; Brennan MF
    J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What prognostic factors are important in duodenal adenocarcinoma?
    Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
    Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
    Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
    Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
    Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
    Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the TNM-classification for small bowel cancer.
    Contant CM; Damhuis RA; van Geel AN; van Eijck CH; Wiggers T
    Hepatogastroenterology; 1997; 44(14):430-4. PubMed ID: 9164514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.
    Sarela AI; Brennan MF; Karpeh MS; Klimstra D; Conlon KC
    Ann Surg Oncol; 2004 Apr; 11(4):380-6. PubMed ID: 15070597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after surgical resection for duodenal adenocarcinoma in the UK.
    Solaini L; Jamieson NB; Metcalfe M; Abu Hilal M; Soonawalla Z; Davidson BR; McKay C; Kocher HM;
    Br J Surg; 2015 May; 102(6):676-81. PubMed ID: 25776995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of resection in the management of duodenal adenocarcinoma.
    Kaklamanos IG; Bathe OF; Franceschi D; Camarda C; Levi J; Livingstone AS
    Am J Surg; 2000 Jan; 179(1):37-41. PubMed ID: 10737576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of primary duodenal adenocarcinoma.
    Hu JX; Miao XY; Zhong DW; Dai WD; Liu W; Hu W
    Hepatogastroenterology; 2006; 53(72):858-62. PubMed ID: 17153441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
    Gold JS; Tang LH; Gönen M; Coit DG; Brennan MF; Allen PJ
    Ann Surg Oncol; 2007 Nov; 14(11):3159-67. PubMed ID: 17680313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
    Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
    Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenocarcinoma of the duodenum. Contribution to the study of a rare pathology].
    Vuilleumier H; Cuttat JF; Blum AL; Chapuis G
    Helv Chir Acta; 1994 Apr; 60(4):557-67. PubMed ID: 7913459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical procedure depending on the depth of tumor invasion in duodenal cancer.
    Kato Y; Takahashi S; Kinoshita T; Shibasaki H; Gotohda N; Konishi M
    Jpn J Clin Oncol; 2014 Mar; 44(3):224-31. PubMed ID: 24470586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
    Poultsides GA; Huang LC; Cameron JL; Tuli R; Lan L; Hruban RH; Pawlik TM; Herman JM; Edil BH; Ahuja N; Choti MA; Wolfgang CL; Schulick RD
    Ann Surg Oncol; 2012 Jun; 19(6):1928-35. PubMed ID: 22167476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.